Vascular Inflammation Stratified by Body Size Phenotype
1 other identifier
observational
250
1 country
1
Brief Summary
- Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
- Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
- Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 28, 2013
CompletedFirst Posted
Study publicly available on registry
November 8, 2013
CompletedNovember 8, 2013
November 1, 2013
3 years
October 28, 2013
November 3, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
max TBR values stratified by the four body size phenotypes
12 weeks
Secondary Outcomes (1)
Framingham risk scores according to the four body size phenotypes
12 weeks
Eligibility Criteria
Healthy volunteers who underwent a medical health check in the health promotion center in Korea University Guro Hospital
You may qualify if:
- Healthy patients for visiting routine medical check in our clinic
You may not qualify if:
- history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
- stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
- history of inflammatory conditions that affect the study results
- taking medications that might affect inflammatory status, including steroid and non-steroidal anti-inflammatory drug within 6 months
- or malignancy or severe renal or hepatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Korea Universitylead
Study Sites (1)
Korea University Guro Hospital
Seoul, South Korea
Related Publications (1)
Yoo HJ, Kim S, Hwang SY, Hong HC, Choi HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Vascular inflammation in metabolically abnormal but normal-weight and metabolically healthy obese individuals analyzed with (1)(8)F-fluorodeoxyglucose positron emission tomography. Am J Cardiol. 2015 Feb 15;115(4):523-8. doi: 10.1016/j.amjcard.2014.11.036. Epub 2014 Nov 29.
PMID: 25529544DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 28, 2013
First Posted
November 8, 2013
Study Start
March 1, 2008
Primary Completion
March 1, 2011
Last Updated
November 8, 2013
Record last verified: 2013-11